B-cells are recognized as crucial mediators of the immune dysregulation observed in SLE, with their abnormal differentiation, development, B-cell receptor (BCR) signaling disturbances, and hyperactivity being central to the progression of disease [3, 4]. The gene discussed is BCR; the disease is systemic lupus erythematosus.